Deep contrastive learning framework identifies cell-type-specific drug targets in Alzheimer's disease.

Yang Y, Xu J, Hou Y, Zhou Y, Saykin AJ, Cheng F

Open source

DOI
10.1002/dad2.70406
Published
2026 Jul-Sep
Container
Alzheimer's & dementia (Amsterdam, Netherlands)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/dad2.70406,
  title = {Deep contrastive learning framework identifies cell-type-specific drug targets in Alzheimer's disease.},
  author = {Yang Y and Xu J and Hou Y and Zhou Y and Saykin AJ and Cheng F},
  year = {2026},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  doi = {10.1002/dad2.70406},
  url = {https://doi.org/10.1002/dad2.70406}
}

RIS

TY  - JOUR
TI  - Deep contrastive learning framework identifies cell-type-specific drug targets in Alzheimer's disease.
AU  - Yang Y
AU  - Xu J
AU  - Hou Y
AU  - Zhou Y
AU  - Saykin AJ
AU  - Cheng F
PY  - 2026
JO  - Alzheimer's & dementia (Amsterdam, Netherlands)
DO  - 10.1002/dad2.70406
UR  - https://doi.org/10.1002/dad2.70406
ER  - 

APA

Y, Y., J, X., Y, H., Y, Z., AJ, S., & F, C. (2026). Deep contrastive learning framework identifies cell-type-specific drug targets in Alzheimer's disease.. Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.70406

Source records